No-Reflow Reversibility: A Study Based on Serial Assessment of Multiple Biomarkers

Volume: 6, Issue: 5, Pages: 798 - 807
Published: Sep 6, 2013
Abstract
No-reflow after primary percutaneous coronary intervention (pPCI) may be reversible. 40 patients undergoing pPCI were evaluated by assessing either improvement or lack of changes regarding angiographic and electrocardiographic indexes of no-reflow between admission and pre-discharge. Myeloperoxidase (MPO; in nanograms per milliliter), C-reactive protein (CRP; in milligrams per liter), endothelin-1 (ET-1; in nanograms per milliliter),...
Paper Details
Title
No-Reflow Reversibility: A Study Based on Serial Assessment of Multiple Biomarkers
Published Date
Sep 6, 2013
Volume
6
Issue
5
Pages
798 - 807
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.